The results of the network screening of core targets showed that AKT1, IL6, VEGFA, and TNF were the top 4 core target proteins in terms of degree value, and maybe the most core targets for the treatment of sinus bradycardia with Yohimbe. This evidence concerns the gene IL6 and Sinus bradycardia.